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Abstract
Background: Effective and timely case management remains one of the fundamental pillars for control of malaria. Tanzania
introduced artemisinin-combination therapy [ACT] for uncomplicated malaria; however, the policy change is challenged by
limited availability of ACTs due to high cost. This study aimed to determine factors influencing prompt access to ACTs
among febrile children in rural Kilosa, Tanzania.
Methods and Findings: In a community-based study, 1,235 randomly selected children under five were followed up weekly
for six months, in 2008. Using a structured questionnaire, children’s caretakers were asked about the child’s febrile history in
the last seven days, and treatment actions including timing, medicines used and source of care. Caretakers’ knowledge
about malaria and socioeconomic and demographic data were also obtained. About half of followed-up children had at
least one episode of fever. Less than half (44.8%) of febrile children were taken to government facilities. Almost one-third
(37.6%; 95% CI 33.1–42.1) of febrile children had prompt access to ACT. Care-seeking from a government facility was the
overriding factor, increasing the likelihood of prompt access to an ACT 18 times (OR 17.7; 95% CI 10.55–29.54; adjusted OR
16.9; 95% CI 10.06–28.28). Caretakers from the better-off household (3rd–5th quintiles) were more likely to seek care from
government facilities (OR 3.66; 95% CI 2.56–5.24; adjusted OR 1.80; 95% CI 1.18–2.76). The majority of antimalarials accessed
by the poor were ineffective [86.0%; 295/343], however, they paid more for them (median Tsh 500) compared to the better-
offs (median Tsh 0).
Conclusions: Prompt access to ACT among febrile children was unacceptably low, due mainly to limited availability of
subsidised ACT at the location where most caretakers sought care. There is urgent need to accelerate implementation of
strategies that will ensure availability of ACT at an affordable price in remote rural areas, where the burden of malaria is
highest.
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Introduction
Effective malaria case management, that is, early diagnosis and
prompt treatment of malaria patients, remain to be one of the
fundamental pillars of malaria control measures. The current
advocated global targets include achievement, by 2010, of univer-
sal coverage of all malaria patients diagnosed and treated with
effective antimalarial medicines within one day of the onset of
illness [1]. Additionally, the target of the Roll Back Malaria [1]
Partnership is to have, by 2010, at least 80% of children underfives
receiving effective treatment with an ACT, within 24 hours of the
onset of symptoms. The implementation of such policy change is
not without challenges, and hence, research is an important tool to
better understand barriers and best practices [2]. Several studies
have been conducted across Africa, following the introduction of
ACT policy [3,4], mostly evaluating implementation of the policy
change at facility level, and specifically on the availability of drugs
and the clinicians’ prescribing habits. Very few studies have
explored the implications of policy change for access to treatment
in the community [5,6]. Notwithstanding, a study conducted by
Gitonga et al in Kenya reported that only 10% of the children
with fever had access to ACT within 48 hours, while Tipke et al
reported no children in Burkina Faso gained access despite the
policy change [5,6].
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mortality accounts for over 40% of out-patient attendances and
36% of all death in under fives [National Malaria Control
Programme - Medium term malaria strategic plan, 2008–2013].
Tanzania accommodated the malaria treatment policy change for
uncomplicated malaria from sulphadoxine-pyrimethamine (SP) to
ACT in October 2006 [Ministry of health and social welfare,
National guideline for malaria diagnosis and treatment, 2006].
However, procurement of ACT is mainly through the support of
funding from the Global Fund to Fight AIDS, Tuberculosis and
Malaria and caters for ACT provision by government and not-for-
profit private health facilities, which include Faith Based Organi-
sation [FBO] facilities. In the former, free services are provided to
under-fives,whereasinthelatter,aconsiderablefeeischarged,even
if the ACT is free. Furthermore, most treatment for malaria is
provided outside the formal healthcare sector, usually by shop-
keepers where treatment is often inappropriate [7]. Recently, the
country introduced an ‘Accredited Drug Dispensing Outlet’
(ADDO) system in which drug stores that normally sell non-
prescription medications are licensed to sell a selected number of
prescription-only pharmaceuticals, including the recommended
ACT, that is, artemether-lumefantrine (ALu). Tanzania is one of
thecountriesinvitedbytheAffordableMedicineFacilityformalaria
[AMFm] to implement a new global health initiative that aims to
lower ACT prices [8] that will benefit even the private sector.
A recent Malaria Indicator Surveys (MIS) conducted in
Tanzania revealed that only 13% of the febrile children had
prompt access to the ACT [National Malaria Control Programme,
2009: Summary of five household surveys to monitor population-
level coverage and impact of malaria interventions in Tanzania,
2007–08]. Studies conducted prior to ACT era indicated availa-
bility of medicines, source of care, perceptions about causes and
the severity of illness, the efficacy of treatment, the ability to pay,
and the distance to the health facility as factors influencing timely
access to malaria treatment [9,10]. Normative data on factors
influencing the prompt access to ACT are necessary to inform
implementation of drug policy change [7,11]. Therefore, this study
was conducted in order to determine the magnitude of, and
identify factors influencing prompt access to ACT among under-
five children in rural Kilosa, Tanzania.
Materials and Methods
Study area
Kilosa district is situated about 300 kilometres west of Dar es
Salaam, the largest business city in Tanzania. The district has
about 488,000 people, of which 79,000 are under five years
[National Census, 2003]. Administratively, the district has seven
divisions with 161 registered villages and is divided into four
geographic-climatic areas: wet-highland, dry-highland, wet-low-
land and dry-lowland [District annual report, 2002]. The district
has an under-five mortality of 166 per 1,000, and about 32% of
the people live below the poverty line [District Medical Officer’s
Report, 2006]. The main sources of income are farming and
livestock keeping. Food crops produced at subsistence level are
maize (staple food), cassava, rice and sorghum. In 2007, malaria
accounted for more than half [55.5%] of the total outpatient
attendance, and 60% of the total deaths among under-fives
admitted to the hospitals [District Annual Report, 2008]. Malaria
transmission in the wet-lowland area occurs throughout the year,
with the highest incidence during and soon after the rain season,
March to June.
Kilosa has 71 health facilities, comprised of 3 hospitals, 7 health
centres and 61 dispensaries [District Annual Report, 2008]. Of
these, two hospitals, one health centre and nine dispensaries
belong to FBOs, and charge a fee for consultation, drugs and
laboratory tests. In the public facilities, services for under-fives are
offered free of charge. There were 152 drug shops in the district,
most of them found in urban and semi-urban areas. At the time of
the study, about 92 drug shops met the minimum criteria set by
the Tanzania Food and Drug Agency (TFDA) and were upgraded
to the status of ADDO, which allowed them to sell artemether-
lumefantrine (ALu). ADDOs are able to purchase ALu at a
subsidised price and charge a flat rate of US $0.50 for one
paediatric treatment course [Stakeholders’ Meeting Report on
ADDO Program, Ministry of Health and Social Welfare, July
2008].
Study design sample size and selection
This is a prospective study design, in which 1,200 randomly
selected children aged 3–59 months were followed up at their
homes weekly for six months, in 2008. Weekly follow ups were
chosen so as to maximize recall of events. The outcome measure
was prompt access to ACT among children who had fever episode
as reported by the caretaker. Fever was used as a proxy for malaria
given the absence in rural areas of laboratory facilities for
diagnosing malaria and the national treatment guidelines that
advised treating childhood fevers suspected to be malaria with the
recommended first-line treatment. This proved for us to be of
practical use as reported by other researchers [5,6,9].
Stratified random sampling was performed by dividing rural
villages into the four geographic-climatic areas, wet-highland, dry-
highland, wet-lowland and dry-lowland, using a list of villages
from the national census. In each area, one village was randomly
selected from among villages with health facilities, and two from
those without, making a total of 12 villages. Under-five children
were randomly selected from village registers. Village registers are
kept by the Village Executive Officer in all villages within the
country. However, in many villages these registers were not up-to-
date. Therefore, village registers had to be updated by the
researchers with the assistance from the village health workers
(VHWs) via house-to-house visits. A sample size of 1,200 was
thereby apportioned to the 12 villages, according to village
population size and random selection was performed using EPI-
INFO, software (version 6). The sample size was derived by
requiring a maximum length of 95% confidence interval +/25%
units, and assumed a proportion of 50%. Adding 10% for possible
loss to follow-up, and 38% correction factor for clustering effect on
village level [ICC=0.01], the total sample size came to 583
(approximated to 600). Available data reported by patients/
caretakers indicated that the 2-week period incidence of fever
suspected to be due to malaria in Tanzania was 6% [12].
Assuming, 6 out of 100 children developed fever in a 2-week
period, we needed to follow-up 1,200 children for 16 weeks in
order to attain a sample size of 600. ACT is not recommended in
very young children (according to manufacturer’s instructions)
and, therefore, only children aged 3–59 months with caretakers
who were residents for at least six months were enrolled.
Data collection procedure
Two to four VHWs were recruited in each village, depending
on the village size. These were centrally trained for six days on the
purpose of the study, data collection procedures and ethical issues.
Three research assistants [13], each responsible to four villages,
were recruited to supervise the VHWs.
Baseline and follow-up questionnaires were developed based on
previous literature [12,14] and were refined after a 2-week pilot-
test in two of the villages. At enrolment of the study children, RAs
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data were collected on demographic characteristics, socioeconom-
ic status [SES] and knowledge about malaria. Thereafter, VHWs
followed up enrolled children every Saturday and Sunday to find
those who had developed fever in the week preceding, and also
interviewed caretakers using the structured questionnaire. During
the interviews, fever episode were recorded and included other
accompanying symptoms, where care was sought and the type of
treatment obtained. The date and time (categorised as morning,
afternoon and night) of fever onset and the administration of ALu
(dawa mseto) were obtained from caretaker’s report. Children, who
had not recovered at the time of the interview, completed their
information on what happened after the previous encounter
during the next round. Children found to have severe symptoms
on the day of interview were advised to be taken immediately to
the health facility.
In government health facilities, medical notes are written in
notebooks and are kept by caretakers. These, as well as drug
containers, were examined to verify the type of drug provided.
Where such evidence was not available, verification was per-
formed by displaying samples of locally available brands [15].
Distance was estimated by the RAs by charting mileage to the
nearest governmental facility by using motorcycles. On each
Monday, meetings were held with VHWs and RAs, where forms
were collected and scrutinised for accuracy.
Data analysis
Data were double entered into EpiData 3.0 [EpiData Associa-
tion. Odense, Denmark] and analysed using STATA version 10.1
[Stata Corp., College station, TX, USA]. The outcome measure
was ‘prompt access to ACT’ which was defined as treatment with
any type of ACT on the same or the next day of fever onset [5,10].
Dates were used instead of hours in calculating promptness
because of difficulties in reporting the time in communities where
the majority of people do not have watches [10]. The outcome
variable was binary, coded as child received the ACT or not. Since
no child had the ACT from more than one source, no confusion
arose from seeking care through multiple sources. Analysis was
based on the first fever episodes. Since each child had at least one
episode, each first episode represented a child. This was done in
order to ensure equal representation of the study subjects and to
avoid within-child dependencies. Separate analysis for episode 2 to
6 could not be done due to small sample size. In addition, the
predictors for a child’s access to ACT would hardly change over a
short time period of six months. SES was calculated using
Principal Component Analysis in which 19 assets adopted from
the Tanzania Demographic Health Survey were used [16].
Variables that had 90% or more of the study children in one
category were excluded. The final list included material compos-
ing the floor, walls and the roof; the source of drinking water and
type of light; and ownership of a mattress, an iron, a bednet, a
bicycle and a sofa. The first component explained 37.4% of the
variability. SES index was categorised in five quintiles. Households
in the first and second quintiles were classified as poor and the
others as better-offs, after initial analysis showed no statistically
significant association of each quintile with the outcome variable.
We also collected data on the cost of antimalarials and other drugs,
as well as other services such as laboratory services, and expen-
diture resulting from seeking care. The latter included, for
example, hiring a bicycle and buying food on the way. However,
we conducted analysis based on the expenditure for drugs because
of inconsistencies in reporting other items. The number of under-
fives and the total number of people residing in a household were
also recorded. The hypothesis was that many under-fives might
pose a burden to the caretaker, in carrying them to the facilities if
no one is at home; while small families give no option for the
caretaker to leave the household chores to someone else.
Bivariate analysis was performed on variables likely to influence
the prompt access to the ACT as well as the source of care. All
variables that were found to have a statistically significant
association were introduced into the multiple regression models
using stepwise analysis, with a cut-off point of 0.10. All regression
analysis were weighted. Post-stratification weighting was done at
the strata level (wet highland, dry highland, wet lowland, dry
lowland) after observing that the sampling proportion did not
perfectly match the true distribution of the population. Odds ratios
[OR] with 95% confidence intervals [CI] were used to measure
association. Significance was tested at the 5% level. Variables
introduced in the multiple regression model to determine an
association of prompt access to the ACT were the total number of
people in the household, number of under fives, the source of care,
severe symptoms (loss of consciousness or ‘malaria had gone to the
head’, cerebral malaria), separate individual symptoms, SES,
knowledge on the recommended drug for the treatment of uncom-
plicated malaria (malaria ya kawaida) and knowledge about the
causes of convulsion to children. The total number of people in the
household and all individual symptoms except cough were found
not statistically significant. The rest of the variables were intro-
duced in a stepwise analysis multiple regression model where only
the source of care and knowledge on the recommended drug for
the treatment of uncomplicated malaria were retained in the final
model. In determining factors influencing care-seeking from
government health facilities the same variables used in the
previous model were analysed. Failure to feed, cough, SES and
knowledge of treatment for uncomplicated malaria and knowledge
about the cause of convulsions were found to be statistically
significant. These were introduced in a stepwise regression model
and all variables except cough and knowledge on cause of
convulsion were retained in the final model.
Ethical clearance
Ethical clearance was obtained from the Muhimbili University
of Health and Allied Sciences and the National Institute for
Medical Research (NIMR), Tanzania. Permission to conduct the
study was also obtained from the regional and district authorities.
A written informed consent was obtained from each adult
caretaker of the child during baseline data collection.
Results
During the six-month collection period, 35 children were added
to the enrolment after children, who had either attained the age of
60 months or who were reported to have migrated during the
study period, were replaced by random selection. In all, 1,235
children aged 3–59 months were enrolled. There was no difference
between febrile and non-febrile children in relation to the socio-
demographic characteristics of the children and their caretakers
(Table 1). The median age of children who had fever was 28.0
months, and that of their caretakers was 28 years. In total, 957
episodes of fever were recorded from 607 children, ranging
between one and six episodes per child.
Source of care
Out of the 607 children with fever, 264 (44.8%; 95% CI 40.3–
49.4) were taken to government health facilities for care in the
course of their illness (Figure 1). No caretaker sought care from the
same source twice and a child who was taken to a government
facility, whether as first or second option, was regarded as having
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to government health facilities, nearly half (44.6%; 153/343) were
taken to ordinary shops, 21.6% (74/343) to FBO facilities, 15.5%
(53/343) to drug shops or ADDOs, 12.8% (44/343) had home
care, 5.0% (17/343) went to traditional healers, and 0.6% (2/343)
to private facilities.
Type of treatment obtained and costs
Of the 607 children, 374 (weighted: 66.3%; 95% CI 62.2–70.4)
received antimalarials, of which, 268 (45.8%; 95% CI 41.2–
50.5%) were ACT, and all were ALu. The majority of those who
were taken to government health facilities were treated with ALu
(83.3%; 220/264), while only 14.0% (48/343) of those who were
taken to the other facilities received ALu. Children from the
better-off household (3
rd–5
th quintiles) were more likely to receive
ALu (52.4%; 195/372) compared to the poor (31.1%; 73/235),
(p-value,0.001).
The average expenditure on drugs reported by caretakers was
Tanzanian shillings (Tsh) 767 (95% CI; Tsh 633–902), and the
median was Tsh 200 (1,200 Tsh equivalent to US dollar 1). The
median expenditure on drugs at government health facilities was
zero. Within the private sector, the median expenditure on drugs
was highest among FBO facilities (Tsh 2,500) followed by ADDO
(Tsh 1,600) and drug shops (Tsh 900). Median expenditure was
least at ordinary shops (Tsh 500). Caretakers from the poor
households paid more compared to the better-offs, median expen-
diture Tsh 500 and zero, respectively.
Factors influencing promptness of access to ACT
Overall, 223 of 607 (37.6%; 95% CI 33.1–42.1) of the children
who had fever received ALu promptly. Prompt access to the ACT
was higher (70.1%; 185/264) among children taken to the
government health facilities compared to those taken elsewhere
(11.1%; 38/343), see Figure 1. Prompt access to the ACT at FBO
facilities and ADDOs were 31.4% (27/86) and 21.4% (6/28),
respectively.
Seeking care from a government health facility and knowledge
that dawa mseto (CoartemH) is the recommended drug for the
treatment of malaria ya kawaida [uncomplicated malaria] influ-
enced prompt access to ACT. Together, the two factors explained
for 30% of the variability. Table 2 shows that the odds of getting
prompt access to the ACT was about 18-times higher among
children seeking care from government health facilities compared
to those who were taken elsewhere (OR 17.7; 95% CI 10.55–
29.54; adjusted OR 16.9; 95% CI 10.06–28.28). Although
univariate analysis showed that children from better-off house-
holds were 2-times more likely to access the ACT promptly than
the poor this effect was diluted when other variables were
introduced in the regression model.
Further analysis by geographic-climatic strata showed a similar
pattern with regard to the source of care, except in the wet-
highland stratum where the association was less remarkable (OR
3.91; 95% CI 1.33–11.47) (Table 2). In the wet-lowland area,
children whose caretakers were knowledgeable of the recom-
mended drug for the treatment of uncomplicated malaria (malaria
Table 1. Background characteristics of study population by reported fever status and their caretakers.
Characteristics of parent and child Reported to have had no fever [n=628] Reported to have had fever[n=607] Total
Number % Number % Number
Caretaker’s age
,30 year 358 51.5 337 48.5 695
30+ years 270 50.0 270 50.0 540
Child’s age
,2 years 227 44.9 279 55.1 506
2+ years 401 55.0 328 45.0 729
Child’s sex
Male 319 50.2 316 49.8 635
Female 309 51.5 291 48.5 600
Socio-economic status (quintiles)
1 Lowest 162 56.1 127 43.9 289
2 Second 130 54.6 108 45.4 238
3 Middle 117 54.7 97 45.3 214
4 Fourth 118 47.4 131 52.6 249
5 Highest 101 41.2 144 58.8 245
Marital status
Not married 229 52.1 211 47.9 440
Married 399 50.2 396 49.8 795
Education in years
,7 years 244 52.3 223 47.7 467
7+ years 384 50.0 384 50.0 768
Distance to government facility
5+ km 337 58.1 243 41.9 580
,5 km 291 44.4 364 55.6 655
doi:10.1371/journal.pone.0012104.t001
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(OR 10.8; 95% CI 2.6–44.6, adjusted OR 7.76; 95% CI 1.54–
39.08) compared to those who did not have the knowledge, see
Table 2.
Factors influencing seeking care from government health
facilities
Since seeking care from a government health facility was the
main factor associated with prompt access to the ACT, further
analyses was done to determine factors that influence seeking care
from these facilities. Table 3 shows that caretakers who knew that
ALu (Dawa mseto) is the recommended drug for the treatment of
uncomplicated malaria (malaria ya kawaida), were more likely to
take their children to a government health facility compared to
those who did not know (OR 2.55; 95% CI 1.71–3.81; adjusted
OR 2.06; 95% CI 1.31–3.25). Knowledge about mosquitoes, and
that high fever causes convulsion in children, increased the
likelihood of taking a child to a government health facility in dry-
highland areas; however, the difference was not significant (OR
3.0; 95% CI 1.29–7.14; adjusted OR 2.43; 95% CI 0.77–7.71).
Children from the better-off households were twice more likely
to be taken to a government health facility compared to those from
poor households (OR 3.22; 95% CI 2.10–4.92; adjusted OR 1.89;
95% CI 1.19–3.03). Moreover, the better-offs were found to live
closer to government health facilities (weighted median, 2 km)
compared to the poor (weighted median, 5 km). Further analysis
showed that the better-offs were 4-times more likely to have
knowledge on the recommended drug for treatment of uncompli-
cated malaria (OR 3.74; 95% CI 2.65–5.28), and that they were
more likely (2.5-times) to own radios compared to the poor (OR
2.35; 95% CI 1.68–3.30).
Discussion
This study shows that nearly two-third of the children with fever
received antimalarials on the same or next day of the onset of
fever, of which less than half were ALu. Furthermore, only one-
third of the children had prompt access to the ACT, and that
seeking care from government health facilities was the major
determining factor. The study has also shown that, despite subsidy
on ACT, the poor were paying more, as compared to the better-
offs, for the ineffective drugs they got from non-government
facilities simply because they had less access to government health
facilities. Previous studies have also reported source of care as one
of several factors influencing access to antimalarials [9,10].
However, it was an overriding factor influencing access to prompt
ACT in this study. The main difference between this study and
others is that, previous studies were conducted when chloroquine
(CQ) or SP were the recommended first-line drugs which could be
obtained easily and at a very cheap price, even in ordinary shops
[17,18,19,20]. The current study is the first to report on factors
influencing access to ACT, and underscores the fact that, when it
comes to accessing an expensive drug such as ACT, in a setting
where subsidy is limited to some facilities, the source of the care
becomes the main determinant to prompt access.
Encouragingly, prompt access to the ACT was very high among
children taken to government health facilities, in this study.
However, the fact that less than half of these children were taken
Figure 1. Flowchart showing the number of enrolled children by type of provider sought, treatment given and promptness of
access to artemisinin combined therapy.
doi:10.1371/journal.pone.0012104.g001
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did not seek care from government health facilities where the ACT
was provided free of charge. This can be explained by the findings
from previous studies that reported caretakers residing closer to a
government health facility were more likely to seek care from these
facilities [21,22]. The present study found that the better-offs were
living closer to government health facilities and had better
knowledge on the recommended treatment compared to the poor.
The majority of caretakers who did not seek care from
government health facilities were from the poor households, this
confirms the ‘inverse care law’ stating that ‘‘the availability of good
medical care tends to vary inversely with the need for the
population served’’ [23]. Unlike with previous studies where the
better-offs were reported to access the recommended antimalarials
by paying more in non-government facilities [24], in the current
study, it was the poor who paid more for the inappropriate drugs
bought at non-government facilities. This irony serves as another
evidence of the uniqueness of ACT as an effective antimalarial, but
with limited subsidy that ends up marginalising the poor.
Subsidy has made ALu quite cheaper thus affordable to many
people. But despite the subsidy, prompt access to the drug was
very low among children taken to FBO facilities and ADDOs.
Most of the FBO facilities are situated in rural remote areas and
serve poor communities. Unfortunately, they charge a consider-
able fee to cover operating costs [25]. This could explain the small
proportion of the febrile children taken to these facilities. Thus,
even if ALu was provided for free, payments for other drugs,
consultation fees and laboratory services would still act as a
Table 2. Determinants of accessing appropriate antimalarials (ACT) on the same or next day (promptly) for children under five
reported to have fever by geographical-climatic strata.
Unadjusted OR Adjusted OR
Prompt access to ACT in all strata* n=607 OR 95% CI OR 95% CI
Seeking care at government health facility 17.7 10.55–29.54 16.87 10.06–28.28
Better-offs [Quintile 3+] 2.1 1.39–3.28
Convulsion and loss of consciousness 1.9 0.57–6.26
Knowledge that high fever or mosquitoes causes convulsion to children 0.7 0.50–1.09
Knowledge that dawa mseto (CoartemH) is the recommended drug for the treatment of malaria ya kawaida
[uncomplicated malaria]
2.04 1.36–3.07 1.26 0.76–2.09
Prompt access to ACT in Wet-Lowland areas n=174
Seeking care at government health facility 19.4 6.5–57.5 16.77 6.55–42.97
Better-offs [Quintile 3+] 0.4 0.1–1.4
Convulsion and loss of consciousness 3.1 0.60–16.4
Knowledge that high fever or mosquitoes causes convulsion to children 0.7 0.34–1.61
Knowledge that dawa mseto (CoartemH) is the recommended drug for the treatment of malaria ya kawaida
[uncomplicated malaria]
10.8 2.6–44.6 7.76 1.54–39.08
Prompt access to ACT in Dry-Lowland areas n=173
Seeking care at government health facility 23.9 9.1–62.8 17.75 7.10–44.37
Better-offs [Quintile 3+] 0.8 0.3–2.2
Convulsion and loss of consciousness** - -
Knowledge that high fever or mosquitoes causes convulsion to children 0.6 0.28–1.18
Knowledge that dawa mseto (CoartemH) is the recommended drug for the treatment of malaria ya kawaida
[uncomplicated malaria]
0.7 0.3–1.9
Prompt access to ACT in Wet-Highland areas n=158
Seeking care at government health facility 3.4 1.0–11.6 3.91 1.33–11.47
Better-offs [Quintile 3+] 1.3 0.4–3.5
Convulsion and loss of consciousness 3.85 0.59–25.1
Knowledge that high fever or mosquitoes causes convulsion to children 1.3 0.54–3.2
Knowledge that dawa mseto (CoartemH) is the recommended drug for the treatment of malaria ya kawaida
[uncomplicated malaria]
1.7 0.6–5.3
Prompt access to ACT in Dry-Highland areas n=102
Seeking care at government health facility 43.5 8.7–216.7 38.34 10.44–140.73
Better-offs [Quintile 3+] 0.6 0.2–2.2
Convulsion and loss of consciousness 2.18 0.13–36.0
Knowledge that high fever or mosquitoes causes convulsion to children 3.0 1.29–7.14 2.43 0.77–7.71
Knowledge that dawa mseto (CoartemH) is the recommended drug for the treatment of malaria ya kawaida
[uncomplicated malaria]
3.0 0.8–11.0
*Weighted.
**Not computed due to inadequate data.
doi:10.1371/journal.pone.0012104.t002
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population lives on less than a dollar per day [District Medical
Officer’s Report, 2006], the average of two US dollars charged by
FBO facilities on drugs cannot be afforded by many. This calls for
a need to examine how FBO facilities can be mobilised in the
strategy to improve prompt access to the ACT, especially, in rural
remote areas. Low utilization of ADDOs might be explained by
the fact these facilities, as well as drug shops, are mostly situated in
urban and semi-urban areas [26]. Hence, the dramatic rise in the
purchase of ACT, reported in the study by Sabot et al (2009),
might not necessarily translate into equitable improvement in
access to ACT in the community [27].
Knowledge that ALu is the recommended drug for the treatment
of uncomplicated malaria was associated with increased prompt
access to the ACT in the wet-lowland areas, where malaria
transmission is high and occurs throughout the year. This might be
an indication of the successful advocacy campaign by the National
Malaria Control Programme. Radio and television adverts and
programmes featuring ALu as the recommended first-line drug have
been aired since the inception of the new drug policy. Such messages
might have been taken more seriously in areas where malaria
transmission is intense. The lack of association between SES and
prompt access to the ACT found in this study might be due to the
overwhelming influence of the source of care which might have
concealed the influence of poverty on prompt access.
Methodological considerations
Diagnosis of malaria relied on caretaker’s report of fever. This
might result in underestimation of prompt access to the ACT since
not all fevers are due to malaria. However, the fact that Kilosa is
hyperendemic area increases the likelihood of most fevers to be due
malaria. Underestimation of prompt access might also have
resulted from including children who were suspected to have
severe malaria and were correctly treated with the second line
antimalarials, or from children who were found to have a negative
blood slide for malaria parasites and were treated with other drugs
[28]. The current WHO treatment policy recommends prompt
parasitological confirmation by microscopy or rapid diagnostic
tests, where available [29]. However, findings from this study,
based on fever as malaria, are still relevant in many areas where
such policy is yet to be fully implemented, and at all levels of service
provision, including the private for and not-for-profit sector.
Ascertainment of the drug given to a child can be difficult,
especially if the caretaker does not know how to read and write.
Therefore samples of the drug packets and records from the
clinician or drug shop were used to verify the type of drug given
[5,15]. Analysis was limited to drug costs due to simplicity in
collecting the data and inconsistencies in reporting other
expenditure items by caretakers.
The use of village health workers with low level of basic
education might have undermined data quality. However, given
the one-week training prior to data collection, the day-to-day close
supervision by RAs and the weekly meetings, the problem of data
quality might have been minimized. Further, the presence of
village health workers might have caused a ‘Hawthorn effect’ likely
to overstate the level of prompt access to the ACT.
Findings from strata analysis should be interpreted with caution
because the sample size for this study was calculated to power the
overall analysis and not the strata specific analysis.
Conclusions
The major drawback to promptly accessing ACTs found in this
study was the limited availability of subsidized ACT in places
where most caretakers took their children for care. And despite
subsidy on the ACT, a majority of caretakers, especially from the
poor households, continue to pay more for ineffective drugs in
non-government facilities.
Government health facilities proved to be the best source for
accessing prompt treatment, as judged by the highest rate of
prompt access to ACTs. Therefore, greater part of the global
effort on malaria should focus on strengthening the public sector.
However, government health facilities were accessed mostly by
the relatively wealthy. Therefore, access to government health
facilities need to be improved by optimizing the location of health
facilities - nearer the malaria hotspots. In the non-government
sector, merely subsidizing the price of ACT is insufficient. In
addition to the subsidy, the quality of services must be regulated
to provide the recommended treatment. Furthermore, informa-
tion must be provided effectively to the poor on the best
treatment and their sources. Further research should address why
prompt access to ACT in ADDOs and FBOs is low despite ACT
subsidy, and how FBO facilities, located mostly in remote rural
areas, can be maximally utilised to reach the marginalized
children.
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